Ligand Pharmaceuticals Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	545.23	413.77	411.45	437.19	362.19	280.38
Revenue Growth (YoY)	53.87%	0.56%	-5.89%	20.71%	29.18%	-
Cost of Revenue	312.5	227.01	210.14	207.16	174.4	147.84
Gross Profit	232.72	186.76	201.3	230.03	187.79	132.54
Selling, General & Admin	58.59	49.19	56.17	46.57	39.44	34.29
Research & Development	50.24	42.97	45.03	41.65	36.55	17.67
Operating Expenses	108.86	92.17	101.16	88.24	76	51.98
Operating Income	123.87	94.59	100.14	141.79	111.79	80.56
Interest Expense	-0.97	-0.59	-0.41	-0.16	-0.07	-0.88
Interest & Investment Income	6.12	6.38	2.47	0.47	0.18	0.09
Earnings From Equity Investments	3.7	3.26	-	-	-	-
Currency Exchange Gain (Loss)	1.85	1.85	0.02	0.53	0.46	0.27
Other Non Operating Income (Expenses)	-13.28	0.22	2.95	0.02	-	-0.05
EBT Excluding Unusual Items	121.27	105.71	105.17	142.64	112.35	79.99
Other Unusual Items	-	-	0.04	-	0	-
Pretax Income	121.27	105.71	105.21	142.64	112.36	79.99
Income Tax Expense	22.38	18.9	18.44	28.88	21.98	16.45
Net Income	98.89	86.81	86.77	113.76	90.38	63.55
Net Income to Common	98.89	86.81	86.77	113.76	90.38	63.55
Net Income Growth	60.28%	0.04%	-23.73%	25.87%	42.22%	-
Shares Outstanding (Basic)	34	34	32	31	31	22
Shares Outstanding (Diluted)	34	34	32	31	32	22
Shares Change (YoY)	0.79%	6.03%	3.21%	-1.17%	43.05%	-
EPS (Basic)	2.91	2.55	2.70	3.67	2.92	2.94
EPS (Diluted)	2.91	2.54	2.69	3.64	2.86	2.88
EPS Growth	59.73%	-5.58%	-26.10%	27.27%	-0.69%	-
Free Cash Flow	-52.78	1.66	140.47	2.65	44.68	59.66
Free Cash Flow Per Share	-1.55	0.05	4.36	0.09	1.41	2.70
Dividend Per Share	2.300	2.300	2.200	3.450	2.500	1.800
Dividend Growth	4.54%	4.54%	-36.23%	38.00%	38.89%	-
Gross Margin	42.68%	45.14%	48.93%	52.62%	51.85%	47.27%
Operating Margin	22.72%	22.86%	24.34%	32.43%	30.86%	28.73%
Profit Margin	18.14%	20.98%	21.09%	26.02%	24.95%	22.66%
Free Cash Flow Margin	-9.68%	0.40%	34.14%	0.61%	12.34%	21.28%
EBITDA	147.42	113.64	118.1	158.09	128.92	94.23
EBITDA Margin	27.04%	27.46%	28.70%	36.16%	35.59%	33.61%
D&A For EBITDA	23.55	19.04	17.96	16.3	17.13	13.67
EBIT	123.87	94.59	100.14	141.79	111.79	80.56
EBIT Margin	22.72%	22.86%	24.34%	32.43%	30.86%	28.73%
Effective Tax Rate	18.46%	17.88%	17.53%	20.24%	19.56%	20.56%
Advertising Expenses	-	-	-	-	6.17	5.22

Source: S&P Global Market Intelligence. Standard template. Financial Sources.